<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
(RULE 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(AMENDMENT NO. 5)*
Coram Healthcare Corp.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.001 par value
--------------------------------------------------------------------------------
(Title of Class of Securities)
218103109
--------------------------------------------------------------------------------
(CUSIP Number)
Richard F. Levy, Esq.
Altheimer & Gray
10 South Wacker Drive
Chicago, Illinois 60606
(312) 715-4600
--------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
OCTOBER 13, 2000
--------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
Schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following
box. / /
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. SEE Rule 13d-7(b) for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934, as amended ("Act"), or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, SEE the NOTES).
<PAGE>
--------------------------------------------------------------------------------
CUSIP No. 218103109 13D Page 2 of 3 Pages
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON
IRS IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):
Ann & Robert H. Lurie Foundation (f/k/a Ann & Robert H. Lurie Family
Foundation)
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) / /
(b) /X/
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. SOURCE OF FUNDS: Not applicable
--------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e):
/ /
--------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION: Illinois
----------------------------------------------------
NUMBER OF
SHARES 7. SOLE VOTING POWER: 3,999,900
BENEFICIALLY
OWNED BY ----------------------------------------------------
EACH
REPORTING 8. SHARED VOTING POWER: -0-
PERSON
WITH ----------------------------------------------------
9. SOLE DISPOSITIVE POWER: 3,999,900
----------------------------------------------------
10. SHARED DISPOSITIVE POWER: -0-
--------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
3,999,900
--------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES: / /
--------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11): 8.1% (1)
--------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON: OO (Illinois not-for-profit corporation)
--------------------------------------------------------------------------------
(1) Based on 49,638,452 shares of Common Stock outstanding as of July 24, 2000,
as reported in the Issuer's most recent Form 10-Q.
<PAGE>
Item 1. SECURITY AND ISSUER.
This statement constitutes Amendment No. 5 to the Statement on
Schedule 13D (the "Schedule 13D") filed with the Securities Exchange
Commission ("SEC") on July 18, 2000, as amended by that certain Amendment No.
1 filed with the SEC on July 27, 2000, as amended by that certain Amendment
No. 2 filed with the SEC on August 18, 2000, as amended by that certain
Amendment No. 3 filed with the SEC on September 1, 2000, as amended by that
certain Amendment No. 4 filed with the SEC on October 13, 2000, and relates
to the shares of common stock, $0.001 par value (the "Common Stock") of Coram
Healthcare Corp., a Delaware corporation ("Issuer").
This Amendment No. 5 is being filed solely to correct typographical
errors to rows 7, 9, 11 and 13 of a cover page of Amendment No. 4 to the
Schedule 13D filed with the SEC on October 13, 2000 ("Amendment No. 4") and
does not amend any other items. Rows 7, 9 and 11 of the cover page of
Amendment No. 4 regarding the shares held by the Ann & Robert H. Lurie
Foundation (the "Lurie Foundation") incorrectly indicated that the Lurie
Foundation has sole voting and dispositive power with respect to 2,115,000
shares of the Issuer's Common Stock. Rows 7, 9 and 11 should have
corresponded with Item 5, which indicated that the Lurie Foundation had sole
voting and dispositive power with respect to 3,999,900 shares of the Issuer's
Common Stock. Row 13 of the cover page to Amendment No. 4 regarding the
shares held by the Lurie Foundation incorrectly indicated that the Lurie
Foundation beneficially owned 4.3% of the Issuer's Common Stock. Rows 13
should have corresponded with Item 5, which indicated that the Lurie
Foundation beneficially owned 8.1% of the Issuer's Common Stock.
Unless otherwise stated herein, the Schedule 13D, as previously amended,
remains in full force and effect. Terms used herein and not defined herein
shall have the meanings ascribed thereto in the Schedule 13D.
The principal executive offices of Issuer are located at 1125 Seventeenth
Street, Suite 2100, Denver, Colorado 80202.
3
<PAGE>
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
Dated: October 20, 2000
ANN & ROBERT H. LURIE FOUNDATION
By: /s/ Ann Lurie
----------------------
Name: Ann Lurie
----------------------
Title: President
----------------------
